Mazor Robotics

Medtronic closed its $1.7 billion acquisition of Mazor Robotics, and announced FDA 510(k) clearance for the jointly developed Mazor X Stealth device.

Mazor Robotics shareholders approved the definitive merger agreement with Medtronic plc, with Medtronic acquiring Mazor for approximately $1.64 billion.

Medtronic plc entered into a definitive merger agreement to acquire all outstanding shares of Mazor Robotics for approximately $1.64 billion, or $1.34 billion net of Medtronic's existing stake and cash acquired.

Mazor Robotics and Medtronic amended their strategic partnership, with Medtronic assuming exclusive worldwide distribution of the Mazor X system and making a $40 million third tranche investment in Mazor. Approximately 30 Mazor sales members are expected to join Medtronic.